CA2101417A1 - Prophylactic and therapeutic treatment of alzheimer's disease - Google Patents
Prophylactic and therapeutic treatment of alzheimer's diseaseInfo
- Publication number
- CA2101417A1 CA2101417A1 CA002101417A CA2101417A CA2101417A1 CA 2101417 A1 CA2101417 A1 CA 2101417A1 CA 002101417 A CA002101417 A CA 002101417A CA 2101417 A CA2101417 A CA 2101417A CA 2101417 A1 CA2101417 A1 CA 2101417A1
- Authority
- CA
- Canada
- Prior art keywords
- calpain
- alzheimer
- disease
- journal
- brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93064792A | 1992-08-14 | 1992-08-14 | |
US930,647 | 1992-08-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2101417A1 true CA2101417A1 (en) | 1994-02-15 |
Family
ID=25459574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002101417A Abandoned CA2101417A1 (en) | 1992-08-14 | 1993-07-27 | Prophylactic and therapeutic treatment of alzheimer's disease |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH06172211A (ko) |
KR (1) | KR940003550A (ko) |
CA (1) | CA2101417A1 (ko) |
TW (1) | TW268896B (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1022276T3 (da) * | 1997-09-04 | 2003-09-29 | Nippon Chemiphar Co | Epoxysuccinamidderivater |
-
1993
- 1993-07-27 CA CA002101417A patent/CA2101417A1/en not_active Abandoned
- 1993-08-12 KR KR1019930015610A patent/KR940003550A/ko not_active Application Discontinuation
- 1993-08-13 JP JP5201519A patent/JPH06172211A/ja active Pending
- 1993-08-23 TW TW082106789A patent/TW268896B/zh active
Also Published As
Publication number | Publication date |
---|---|
JPH06172211A (ja) | 1994-06-21 |
KR940003550A (ko) | 1994-03-12 |
TW268896B (ko) | 1996-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0580161A1 (en) | Prophylactic and therapeutic treatment of Alzheimer's disease | |
Pelletier et al. | Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level | |
Pelletier et al. | Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase | |
JP4439111B2 (ja) | ジペプチドのアポトーシスインヒビターおよびそれらの使用 | |
JP2010031059A (ja) | 筋萎縮性側索硬化症を処置するためのプラミペキソールの使用 | |
JP4316672B2 (ja) | ラムノリピド類の免疫活性 | |
JP3010210B1 (ja) | マトリックスメタロプロテアーゼ産生阻害剤 | |
US20070265208A1 (en) | Association of calpain inhibitors and reactive oxygen species trapping agents | |
JP2005516911A6 (ja) | 筋萎縮性側索硬化症を処置するためのプラミペキソールの使用 | |
US6593362B2 (en) | Non-peptidic cyclophilin binding compounds and their use | |
DE69814072T2 (de) | Caspases und apoptosis | |
US20040014678A1 (en) | Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytoc pathway | |
JPH03130222A (ja) | 新規な治療用組成物 | |
EP0620737B1 (en) | Use of LACTOFERRIN iN the manufacture of a medicament for treating RHEUMATISM | |
CA2101417A1 (en) | Prophylactic and therapeutic treatment of alzheimer's disease | |
JP2013531032A (ja) | マクロラクチンa及びその誘導体を有効成分として含有する抗血管新生組成物 | |
Yuen et al. | Section Review: Central & Peripheral Nervous Systems: Therapeutic potential of calpain inhibitors in neurodegenerative disorders | |
EP0664127B1 (en) | Pharmaceutical compositions containing isoquinoline derivatives | |
KR101270123B1 (ko) | 항산화용 조성물 | |
Olds et al. | Differential immunoregulation of granulomatous inflammation, portal hypertension, and hepatic fibrosis in murine schistosomiasis mansoni. | |
CN111867580B (zh) | 用于预防或改善脱发的包含有效成分董尼酮的组合物 | |
JPH10139665A (ja) | トログリタゾンを含有するグルタチオン還元酵素活性増強剤 | |
CA2207943A1 (en) | Therapeutic agent for joint diseases | |
EP0149847A2 (en) | Therapeutic and preventive agent containing dolichol | |
KR100751051B1 (ko) | 관절염 치료용 약제학적 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |